Skip to Content

  • Search

View Additional Section Content

GOG-3005 - A Phase 3 placebo-controlled study of carboplatin/paclitaxel with or without concurrent and continuation maintenance veliparib (parp inhibitor) in subjects with previously untreated stages III or IV high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer

For more information on this trial, click the link below.

Clinical Trial Categories

  • Ovarian Cancer
Hanjani Institute for Gynecologic Oncology at 215-885-0220


  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory


Schedule a


Clinical Trials Details